Field & Main Bank Decreases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Field & Main Bank decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% during the third quarter, Holdings Channel.com reports. The institutional investor owned 12,123 shares of the healthcare conglomerate’s stock after selling 252 shares during the quarter. UnitedHealth Group accounts for about 2.5% of Field & Main Bank’s portfolio, making the stock its 6th largest position. Field & Main Bank’s holdings in UnitedHealth Group were worth $7,088,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $27,000. Macroview Investment Management LLC boosted its stake in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. Delos Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $31,000. Finally, Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.7 %

NYSE:UNH opened at $615.81 on Friday. The firm has a market cap of $566.72 billion, a P/E ratio of 40.12, a P/E/G ratio of 1.81 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $619.80. The firm has a 50-day simple moving average of $581.93 and a two-hundred day simple moving average of $545.03.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the firm posted $6.56 EPS. Analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.72%.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. Argus increased their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. KeyCorp initiated coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target for the company. Bank of America dropped their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and raised their target price for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.